Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01592565 · ClinicalTrials.gov registry record · NA

Exercise Cardiac Magnetic Resonance Imaging Accuracy for Cardiovascular Stress Testing

A NA study of Coronary Artery Disease, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
227
Enrollment target
3
Study locations

NCT01592565 is a NA study of Coronary Artery Disease that has completed, run by Ohio State University. The registered enrollment target is 227 participants, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (82% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01592565, a NA study of Coronary Artery Disease, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
227 participants
Enrollment target
3
Study locations

Study Summary

This study is being done to demonstrate a powerful new method for detecting heart disease that combines the proven prognostic capability of exercise stress testing with the superior image quality of Cardiac Magnetic Resonance Imaging (CMR). The investigators hope to demonstrate that exercise CMR has equivalent or superior diagnostic accuracy compared to exercise stress SPECT for detecting obstructive artery disease.

Conditions Studied

Interventions

  • OTHER Diagnostic Cardiac Imaging

Study Locations (3)

Ohio

  • The Lindner Center at The Christ Hospital - Cinncinatti
  • The Ohio State University - Columbus

Pennsylvania

  • University Of Pittsburgh Medical Center - Pittsburgh

Trial Details

FieldValue
Enrollment Target 227 participants
Start Date 2010-08
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT01592565

The ClinicalTrials.gov registry entry for NCT01592565 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 227 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (82% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Diagnostic Cardiac Imaging is the first listed.

NCT01592565 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01592565 about?

NCT01592565 is a clinical study titled "Exercise Cardiac Magnetic Resonance Imaging Accuracy for Cardiovascular Stress Testing". This study is being done to demonstrate a powerful new method for detecting heart disease that combines the proven prognostic capability of exercise stress testing with the superior image quality of Cardiac Magnetic Resonance Imaging (CMR). The investigators hope to demonstrate that exercise CMR has...

What is the current status of trial NCT01592565?

This trial is currently completed. It is a NA study. The enrollment target is 227 participants. The study started on 2010-08.

What conditions does trial NCT01592565 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT01592565?

The interventions under investigation include: Diagnostic Cardiac Imaging (OTHER).

Who is sponsoring clinical trial NCT01592565?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01592565 being conducted?

This trial has 3 study locations across Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.